Two existing cancer drugs turn on a gene that tells tumor cells to remain inactive, according to a study led by researchers at the Icahn School of Medicine at Mount Sinai and published today in Nature Communications. Researchers discovered that the gene NR2F1, when…
Source: NR2F1 gene: A ‘master regulator’ of tumor cell growth
No comments:
Post a Comment